OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,457,000 | -2.7% | 372,733 | 0.0% | 0.05% | -9.6% |
Q1 2021 | $1,498,000 | +74.0% | 372,733 | 0.0% | 0.05% | +73.3% |
Q4 2020 | $861,000 | -59.7% | 372,733 | 0.0% | 0.03% | -62.5% |
Q3 2020 | $2,139,000 | -22.1% | 372,733 | 0.0% | 0.08% | -23.8% |
Q2 2020 | $2,747,000 | +147.3% | 372,733 | 0.0% | 0.10% | +110.0% |
Q1 2020 | $1,111,000 | -28.2% | 372,733 | 0.0% | 0.05% | -15.3% |
Q4 2019 | $1,547,000 | +28.1% | 372,733 | 0.0% | 0.06% | +11.3% |
Q3 2019 | $1,208,000 | +75.1% | 372,733 | 0.0% | 0.05% | +89.3% |
Q2 2019 | $690,000 | -21.6% | 372,733 | -25.0% | 0.03% | -22.2% |
Q1 2019 | $880,000 | -26.8% | 496,977 | 0.0% | 0.04% | -29.4% |
Q4 2018 | $1,203,000 | -60.4% | 496,977 | -7.2% | 0.05% | -53.6% |
Q3 2018 | $3,038,000 | -27.3% | 535,824 | 0.0% | 0.11% | -30.8% |
Q2 2018 | $4,179,000 | +10.3% | 535,824 | 0.0% | 0.16% | +8.2% |
Q1 2018 | $3,788,000 | -28.4% | 535,824 | 0.0% | 0.15% | -27.9% |
Q4 2017 | $5,289,000 | +279.7% | 535,824 | +229.7% | 0.20% | +308.0% |
Q3 2017 | $1,393,000 | -73.4% | 162,537 | -69.7% | 0.05% | -74.2% |
Q2 2017 | $5,229,000 | – | 535,824 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |